Total Funding
25
66
Total FundingSeries A raised
Growth Score 25 in past quarter
-24 pts
Heat Score 66 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
23286
Inato is a platform designed for clinical trials that can unlock research site potential.
- Kourosh Davarpanah: Co-Founder and CEOPast Role: NeuCoin, Cryptocurrency design
- Jean-David Zeitoun: Chief Medical Officer and Founding Partner
About the Company
Inato automates data structuring and analysis, cross-checks data sources, and provides insights on this data. It features a tool for collecting and analyzing data used in clinical trials, Inato’s AI-powered platform enables pharmaceutical companies to drastically reduce drug development costs. By accelerating clinical trials, Inato helps new
therapies arrive to patients faster, and at lower prices